Phase 3 Lung Injury Clinical Trials
3 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–3 of 3 trials
Recruiting
Phase 2Phase 3
A Study on the Treatment of Patients With Acute Lung Injury Caused by Sepsis Through Microbiota Transplantation
Acute Respiratory Distress Syndrome (ARDS)Acute Lung Injury(ALI)Sepsis Related Acute Lung Injury/Acute Respiratory Distress Syndrome
Shanghai University of Traditional Chinese Medicine60 enrolled1 locationNCT07342205
Recruiting
Phase 2Phase 3
Vadadustat for the Treatment of Nonintubated Acute Respiratory Distress Syndrome Due to Pathogen-Associated Lung Injury
Nonintubated Acute Respiratory Distress Syndrome (ARDS)Pathogen-associated Lung Injury
Bentley J. Bobrow1,100 enrolled1 locationNCT07086755
Recruiting
Phase 2Phase 3
The effect of heparin on lung function following cardiopulmonary bypass.
Lung injury following cardiac surgery.
Nil30 enrolled1 locationACTRN12605000133639